Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 5508-5513

  Wu, Ting Hum ^a   Gu, Xin Xing ^a,b  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; DRUG CARRIER; OLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; TETANUS TOXOID; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; HAEMOPHILUS INFLUENZAE; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032849756     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.5508-5513.1999     Document Type: Article

References (36)

1. Ambrosino, D. M., D. Bolon, H. Collard, R. Van Etten, M. V. Kanchana, and R. W. Finberg. 1992. Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages. J. Immunol. 149:3978-3983.
2. Anderson, P. W., M. E. Pichichero, E. C. Stein, S. Porcelli, R. F. Betts, D. M. Onnuck, D. Korones, R. A. Insel, J. M. Zahradnik, and R. Eby. 1989. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197. J. Immunol. 142:2464-2468.
3. Barenkamp, S. J. 1996. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect. Immun. 64:1246-1251.
4. Barenkamp, S. J., and F. F. Bordor. 1990. Development of serum bactericidal activity following nontypeable Haemophilus influenzae acute otitis media. Pediatr. Infect. Dis. J. 9:333-339.
5. Brinton, C. C., Jr., M. J. Carter, D. B. Derber, S. Kar, J. A. Kramarik, A. C. C. To, S. C. M. To, and S. W. Wood. 1989. Design and development of pilus vaccines for Haemophilus influenzae diseases. Pediatr. Infect. Dis. J. 8:S54-S61.
6. Coffey, J. D., H. N. Booth, and A. D. Martin. 1996. Otitis media in the practice of pediatrics. Bacteriological and clinical observations. Pediatrics 38:25-32.
7. Frasch, C. E. 1990. Production and control of Neisseria meningitis vaccines, p. 123. In A. Mizrahi (ed.), Bacterial vaccine, Alan R. Liss Inc., New York, N.Y.
8. Gnehm, H. E., S. I. Pelton, S. Gulati, and P. A. Rice. 1985. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J. Clin. Investig. 75:1645-1658.
9. Green, B. A., J. E. Farley, T. Quinn-Dey, R. A. Deich, and G. W. Zlotnick. 1991. The e (P4) membrane protein of Haemophilus influenzae biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect. Immun. 59:3191-3198.
10. Green, B. A., E. S. Meredith, L. Edwards, and K. F. Jones. 1994. Nontypeable Haemophilus influenzae lipooligosaccharide conjugates as vaccine candidates against NTHi. Vaccine 94:125-129.
11. Gu, X. X., J. Chen, S. J. Barenkamp, J. B. Robbins, C. M. Tsai, D. J. Lim, and J. Battey. 1998. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1891-1897.
12. Gu, X. X., J. Sun, S. Jin, S. J. Barenkamp, D. J. Lim, J. B. Robbins, and J. Battey. 1997. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect. Immun. 65:4488-4493.
13. Gu, X. X., and C. M. Tsai. 1993. Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide protein conjugates. Infect. Immun. 61:1873-1880.
14. Gu, X. X., C. M. Tsai, M. A. Apicella, and D. J. Lim. 1995. Quantitation and biological properties of released and cell-bound lipooligosaccharide from nontypeable Haemophilus influenzae. Infect. Immun. 63:4115-4120.
15. Gu, X. X., C. M. Tsai, T. Ueyama, S. J. Barenkamp, J. B. Robbins, and D. J. Lim. 1996. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect. Immun. 64:4047-4053.
16. Gupta, R. K., S. C. Szu, R. A. Finkelstein, and J. B. Robbins. 1992. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharides of Vibro cholerae O1 serotype Inaba bound to cholera toxin. Infect. Immun. 60:3201-3208.
17. Haase, E. M., K. Yi, G. D. Morse, and T. F. Murphy. 1994. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect. Immun. 62:3712-3722.
18. Hadjipetrou-Kourounakis, L., and E. Moller. 1984. Adjuvants influence the immunoglobulin subclass distribution of immune responses in vivo. Scand. J. Immunol. 19:219-225.
19. Hoist, O., A. J. Ulmer, H. Brade, H.-D. Flad, and E. T. Rietschel. 1996. Minireview: biochemistry and cell biology of bacterial endotoxins. FEMS Immunol. Med. Microbiol. 16:83-104.
20. Karasic, R. B., C. E. Trumpp, H. E. Gnehm, P. A. Rice, and S. I. Pelton. 1985. Modification of otitis media in chinchillas rechallenged with nontypeable Haemophilus influenzae and serological response to outer membrane antigens. J. Infect. Dis. 151:273-279.
21. Laferriere, C. A., R. K. Sood, J. M. de Muys, F. Michon, and H. J. Jennings. 1997. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity. Vaccine 15:179-186.
22. Liu, M. A., A. Friedman, A. I. Oliff, J. Tai, D. Martinez, R. R. Deck, J. T. Shieh, T. D. Jenkins, J. J. Donnelly, and L. A. Hawe. 1992. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc. Natl. Acad. Sci. USA 89:4633-4637.
23. Liu, V. C., and A. L. Smith. 1992. Molecular mechanisms of HI pathogenicity. Antibiot. Chemother. 45:30-51.
24. Loeb, M. R., A. L. Zachary, and D. H. Smith. 1981. Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J. Bacteriol. 145:596-604.
25. Louis, J. A., and P. H. Lambert. 1979. Lipopolysaccharides: from immunostimulation to autoimmunity. Springer Semin. Immunopathol. 2:215-219.
26. Murphy, T. F., and M. A. Apicella. 1985. Antigenic heterogeneity of outer membrane proteins of nontypeable Haemophilus influenzae is a basis for a serotyping system. Infect. Immun. 50:15-21.
27. Murphy, T. F., L. C. Bartos, P. A. Rice, M. B. Nelson, K. C. Dudas, and M. A. Apicella. 1986. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J. Clin. Investig. 78:1020-1027.
28. Musher, D. M., K. R. Kubitshck, J. Crennaan, and R. E. Baughn. 1983. Pneumonia and acute febrile tracheobronchitis due to H. influenzae. Annu. Infect. Med. 99:344-350.
29. Patrick, C. C., A. Kimura, M. A. Jackson, L. Hermanstorfer, A. Hood, G. H. McCracken, Jr., and E. J. Hansen. 1987. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypeable Haemophilus influenzae. Infect. Immun. 55:2902-2911.
30. Peeters, C. C., A. M. Tenbergen-Meekes, D. E. Evenberg, J. T. Poolman, B. J. Zegers, and G. T. Rijkers. 1991. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J. Immunol. 146:4308-4314.
31. Seppala, I., and O. Makela. 1989. Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. J. Immunol. 143:1259-1264.
32. Sirakova, T., P. E. Kolattukudy, D. Murwin. J. Billy, E. Leake, D. Lim, T. DeMaria, and L. O. Bakaletz. 1994. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect. Immun. 62:2002-2020.
33. Tsai, C. M., C. E. Frasch, E. Rivera, and H. D. Hochstein. 1989. Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage. J. Biol. Stand. 17:249-258.
34. Ueyama, T., X. X. Gu, C. M. Tsai, A. B. Karpas, and D. J. Lim. 1999. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274. Clin. Diagn. Lab. Immunol. 6:96-100.
35. Verheul, A. F. M., G. J. P. H. Boons, G. A. Van der Marel, J. H. Van Boom, H. J. Jennings, H. Snippe, J. Verhoef, P. Hoogerhout, and J. T. Poolman. 1991. Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates. Infect. Immun. 59:3566-3573.
36. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharide extraction with phenol:water and further application of the procedure. Methods Carbohydr. Chem. 5:83-91.